Clinical trial
Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic…
NCT00351052 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00351052 |
|---|---|
| Title | Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis |
| Official title | A 24-Week, Randomized, Multicenter, Parallel-Group, Double-Blind, Vehicle-Controlled Study on Pimecrolimus Cream 1% Assessing the Steroid-Sparing Effect in the Long Term Management of Pediatric Patients With Severe Atopic Dermatitis |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis |
| Intervention type | Drug |
| Interventions | Pimecrolimus, Placebo |
| Enrollment | 184 |
| Start date | Dec 1, 2001 |
| Completion | Sep 1, 2004 |
| First posted | Jul 12, 2006 |
| Last update posted | Jan 17, 2008 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: